Aurinia Pharmaceuticals Inc. Balance Sheet
AUPH / Health Care|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Aurinia Pharmaceuticals Inc. had $752M in total assets and $581M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | $83.4M | $48.8M | $231.6M | $272.4M | $272.4M | $306.0M | - |
| Inventory | $45.7M | $39.2M | $39.7M | $24.8M | $19.3M | $13.9M | $0 | - |
| Current Assets | $492.0M | $446.6M | $424.8M | $442.5M | $513.3M | $419.4M | $315.1M | - |
| PP&E (Net) | $2.1M | $2.7M | $3.4M | $3.6M | $4.4M | $4.8M | $93.0K | - |
| Total Assets | $751.6M | $550.6M | $548.1M | $470.9M | $543.4M | $463.7M | $324.3M | - |
| Current Liabilities | $93.7M | $97.8M | $77.2M | $46.1M | $40.6M | $32.0M | $11.3M | - |
| Shareholders' Equity | $581.3M | $377.5M | $378.0M | $407.8M | $298.6M | $407.8M | $298.6M | $135.7M |